SQ3370

· Shasqi, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SQ3370, covering 2025-11-14 to 2025-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]